A-kinase anchoring proteins: Molecular regulators of the cardiac stress response

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1833, Issue 4, 2013, Pages 901-908

  Diviani, Dario ^a   Maric, Darko ^a   Pérez López, Irene ^a   Cavin, Sabrina ^a   del Vescovo, Cosmo D ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

A kinase anchoring protein (AKAP); Cardiac remodeling; Cardiomyocyte; Protein kinase A; Signaling

Indexed keywords

AKAP LBC PROTEIN; ANGIOTENSIN II; BETA ADRENERGIC RECEPTOR; CALCINEURIN; CALCINEURIN A BETA; CALCIUM CHANNEL L TYPE; CARRIER PROTEINS AND BINDING PROTEINS; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN 1; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN 6; DYNAMIN RELATED PROTEIN 1; G PROTEIN COUPLED RECEPTOR KINASE 2; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE TRIPHOSPHATASE; HEAT SHOCK PROTEIN 20; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGEN; PHENYLEPHRINE; PHOSPHATIDYLINOSITOL 3 KINASE GAMMA; PHOSPHOLIPASE C; PHOSPHOLIPASE C EPSILON; PROTEIN BCL 2; RYANODINE RECEPTOR 2; TRANSCRIPTION FACTOR NFAT3; UNCLASSIFIED DRUG;

ADAPTATION; APOPTOSIS; CELL DIFFERENTIATION; CELL HYPOXIA; CELL NUCLEUS; CYTOPLASM; GENE SILENCING; HEART; HEART FAILURE; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART STRESS; HEART VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN SYNTHESIS; RECEPTOR DOWN REGULATION; REVIEW; SIGNAL TRANSDUCTION;

A KINASE ANCHOR PROTEINS; ADAPTATION, PHYSIOLOGICAL; ANOXIA; CARDIOMEGALY; CYCLIC AMP; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MYOCARDIUM; MYOCYTES, CARDIAC; OXYGEN; PROTEIN BINDING; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL;

EID: 84875072314     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2012.07.014     Document Type: Review

References (75)

1. Barry S.P., Townsend P.A. What causes a broken heart-molecular insights into heart failure. Int. Rev. Cell Mol. Biol. 2010, 284:113-179.
2. Hill J.A., Olson E.N. Cardiac plasticity. N. Engl. J. Med. 2008, 358:1370-1380.
3. Towbin J.A., Bowles N.E. The failing heart. Nature 2002, 415:227-233.
4. Weber K.T., Sun Y., Diez J. Fibrosis: a living tissue and the infarcted heart. J. Am. Coll. Cardiol. 2008, 52:2029-2031.
5. Cappola T.P. Molecular remodeling in human heart failure. J. Am. Coll. Cardiol. 2008, 51:137-178.
6. Frey N., Katus H.A., Olson E.N., Hill J.A. Hypertrophy of the heart: a new therapeutic target?. Circulation 2004, 109:1580-1589.
7. Beene D.L., Scott J.D. A-kinase anchoring proteins take shape. Curr. Opin. Cell Biol. 2007, 19:192-198.
8. Pawson C.T., Scott J.D. Signal integration through blending, bolstering and bifurcating of intracellular information. Nat. Struct. Mol. Biol. 2010, 17:653-658.
9. Welch E.J., Jones B.W., Scott J.D. Networking with AKAPs: context-dependent regulation of anchored enzymes. Mol. Interv. 2010, 10:86-97.
10. Diviani D. Curr. Opin. Pharmacol. 2008, 8:166-173.
11. Gold M.G., Lygren B., Dokurno P., Hoshi N., McConnachie G., Tasken K., Carlson C.R., Scott J.D., Barford D. Molecular basis of AKAP specificity for PKA regulatory subunits. Mol. Cell 2006, 24:383-395.
12. Kinderman F.S., Kim C., von Daake S., Ma Y., Pham B.Q., Spraggon G., Xuong N.H., Jennings P.A., Taylor S.S. A dynamic mechanism for AKAP binding to RII isoforms of cAMP-dependent protein kinase. Mol. Cell 2006, 24:397-408.
13. Skroblin P., Grossmann S., Schafer G., Rosenthal W., Klussmann E. Mechanisms of protein kinase A anchoring. Int. Rev. Cell Mol. Biol. 2010, 283:235-330.
14. Hulme J.T., Westenbroek R.E., Scheuer T., Catterall W.A. Phosphorylation of serine 1928 in the distal C-terminal domain of cardiac CaV1.2 channels during beta1-adrenergic regulation. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:16574-16579.
15. Marx S.O., Reiken S., Hisamatsu Y., Jayaraman T., Burkhoff D., Rosemblit N., Marks A.R. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 2000, 101:365-376.
16. Hagemann D., Xiao R.P. Dual site phospholamban phosphorylation and its physiological relevance in the heart. Trends Cardiovasc. Med. 2002, 12:51-56.
17. 2+ as a result of phosphorylation of cardiac myosin-binding protein C. J. Gen. Physiol. 2010, 136:615-627.
18. Kentish J.C., McCloskey D.T., Layland J., Palmer S., Leiden J.M., Martin A.F., Solaro R.J. Phosphorylation of troponin I by protein kinase A accelerates relaxation and crossbridge cycle kinetics in mouse ventricular muscle. Circ. Res. 2001, 88:1059-1065.
19. Stelzer J.E., Patel J.R., Walker J.W., Moss R.L. Differential roles of cardiac myosin-binding protein C and cardiac troponin I in the myofibrillar force responses to protein kinase A phosphorylation. Circ. Res. 2007, 101:503-511.
20. Marx S.O., Kurokawa J., Reiken S., Motoike H., D'Armiento J., Marks A.R., Kass R.S. Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science 2002, 295:496-499.
21. Fink M.A., Zakhary D.R., Mackey J.A., Desnoyer R.W., Apperson-Hansen C., Damron D.S., Bond M. AKAP-mediated targeting of protein kinase a regulates contractility in cardiac myocytes. Circ. Res. 2001, 88:291-297.
22. McConnell B.K., Popovic Z., Mal N., Lee K., Bautista J., Forudi F., Schwartzman R., Jin J.P., Penn M., Bond M. Disruption of protein kinase A interaction with A-kinase-anchoring proteins in the heart in vivo: effects on cardiac contractility, protein kinase A phosphorylation, and troponin I proteolysis. J. Biol. Chem. 2009, 284:1583-1592.
23. Christian F., Szaszak M., Friedl S., Drewianka S., Lorenz D., Goncalves A., Furkert J., Vargas C., Schmieder P., Gotz F., Zuhlke K., Moutty M., Gottert H., Joshi M., Reif B., Haase H., Morano I., Grossmann S., Klukovits A., Verli J., Gaspar R., Noack C., Bergmann M., Kass R., Hampel K., Kashin D., Genieser H.G., Herberg F.W., Willoughby D., Cooper D.M., Baillie G.S., Houslay M.D., von Kries J.P., Zimmermann B., Rosenthal W., Klussmann E. Small molecule AKAP-protein kinase A (PKA) interaction disruptors that activate PKA interfere with compartmentalized cAMP signaling in cardiac myocytes. J. Biol. Chem. 2011, 286:9079-9096.
24. Patel H.H., Hamuro L.L., Chun B.J., Kawaraguchi Y., Quick A., Rebolledo B., Pennypacker J., Thurston J., Rodriguez-Pinto N., Self C., Olson G., Insel P.A., Giles W.R., Taylor S.S., Roth D.M. Disruption of protein kinase A localization using a trans-activator of transcription (TAT)-conjugated A-kinase-anchoring peptide reduces cardiac function. J. Biol. Chem. 2010, 285:27632-27640.
25. Scott J.D., Santana L.F. A-kinase anchoring proteins: getting to the heart of the matter. Circulation 2010, 121:1264-1271.
26. Semenza G.L. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci. STKE 2007, cm8.
27. Semenza G.L. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology 2009, 24:97-106.
28. 2-regulated prolyl hydroxylation. Science 2001, 292:468-472.
29. Maxwell P.H., Wiesener M.S., Chang G.W., Clifford S.C., Vaux E.C., Cockman M.E., Wykoff C.C., Pugh C.W., Maher E.R., Ratcliffe P.J. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999, 399:271-275.
30. Nakayama K., Frew I.J., Hagensen M., Skals M., Habelhah H., Bhoumik A., Kadoya T., Erdjument-Bromage H., Tempst P., Frappell P.B., Bowtell D.D., Ronai Z. Siah2 regulates stability of prolyl-hydroxylases, controls HIF1alpha abundance, and modulates physiological responses to hypoxia. Cell 2004, 117:941-952.
31. Wong W., Goehring A.S., Kapiloff M.S., Langeberg L.K., Scott J.D. mAKAP compartmentalizes oxygen-dependent control of HIF-1alpha. Sci. Signal. 2008, 1:ra18.
32. Chan D.C. Mitochondria: dynamic organelles in disease, aging, and development. Cell 2006, 125:1241-1252.
33. Suen D.F., Norris K.L., Youle R.J. Mitochondrial dynamics and apoptosis. Genes Dev. 2008, 22:1577-1590.
34. Ong S.B., Subrayan S., Lim S.Y., Yellon D.M., Davidson S.M., Hausenloy D.J. Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation 2010, 121:2012-2022.
35. Smirnova E., Griparic L., Shurland D.L., van der Bliek A.M. Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. Mol. Biol. Cell 2001, 12:2245-2256.
36. Roux A., Uyhazi K., Frost A., De Camilli P. GTP-dependent twisting of dynamin implicates constriction and tension in membrane fission. Nature 2006, 441:528-531.
37. Huang L.J., Durick K., Weiner J.A., Chun J., Taylor S.S. Identification of a novel dual specificity protein kinase A anchoring protein, D-AKAP1. J. Biol. Chem. 1997, 272:8057-8064.
38. Kim H., Scimia M.C., Wilkinson D., Trelles R.D., Wood M.R., Bowtell D., Dillin A., Mercola M., Ronai Z.A. Fine-tuning of Drp1/Fis1 availability by AKAP121/Siah2 regulates mitochondrial adaptation to hypoxia. Mol. Cell 2011, 44:532-544.
39. Perrino C., Feliciello A., Schiattarella G.G., Esposito G., Guerriero R., Zaccaro L., Del Gatto A., Saviano M., Garbi C., Carangi R., Di Lorenzo E., Donato G., Indolfi C., Avvedimento V.E., Chiariello M. AKAP121 downregulation impairs protective cAMP signals, promotes mitochondrial dysfunction, and increases oxidative stress. Cardiovasc. Res. 2010, 88:101-110.
40. Harada H., Becknell B., Wilm M., Mann M., Huang L.J., Taylor S.S., Scott J.D., Korsmeyer S.J. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. Mol. Cell 1999, 3:413-422.
41. Affaitati A., Cardone L., de Cristofaro T., Carlucci A., Ginsberg M.D., Varrone S., Gottesman M.E., Avvedimento E.V., Feliciello A. Essential role of A-kinase anchor protein 121 for cAMP signaling to mitochondria. J. Biol. Chem. 2003, 278:4286-4294.
42. Sadoshima J., Izumo S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu. Rev. Physiol. 1997, 59:551-571.
43. Zou Y., Akazawa H., Qin Y., Sano M., Takano H., Minamino T., Makita N., Iwanaga K., Zhu W., Kudoh S., Toko H., Tamura K., Kihara M., Nagai T., Fukamizu A., Umemura S., Iiri T., Fujita T., Komuro I. Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II. Nat. Cell Biol. 2004, 6:499-506.
44. Brown J.H., Del Re D.P., Sussman M.A. The Rac and Rho hall of fame: a decade of hypertrophic signaling hits. Circ. Res. 2006, 98:730-742.
45. Pare G.C., Bauman A.L., McHenry M., Michel J.J., Dodge-Kafka K.L., Kapiloff M.S. The mAKAP complex participates in the induction of cardiac myocyte hypertrophy by adrenergic receptor signaling. J. Cell Sci. 2005, 118:5637-5646.
46. Dodge-Kafka K.L., Soughayer J., Pare G.C., Carlisle Michel J.J., Langeberg L.K., Kapiloff M.S., Scott J.D. The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature 2005, 437:574-578.
47. Li J., Negro A., Lopez J., Bauman A.L., Henson E., Dodge-Kafka K., Kapiloff M.S. The mAKAPbeta scaffold regulates cardiac myocyte hypertrophy via recruitment of activated calcineurin. J. Mol. Cell. Cardiol. 2010, 48:387-394.
48. Appert-Collin A., Cotecchia S., Nenniger-Tosato M., Pedrazzini T., Diviani D. The A-kinase anchoring protein (AKAP)-Lbc-signaling complex mediates alpha1 adrenergic receptor-induced cardiomyocyte hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:10140-10145.
49. Abrenica B., AlShaaban M., Czubryt M.P. The A-kinase anchor protein AKAP121 is a negative regulator of cardiomyocyte hypertrophy. J. Mol. Cell. Cardiol. 2009, 46:674-681.
50. Kapiloff M.S., Jackson N., Airhart N. mAKAP and the ryanodine receptor are part of a multi-component signaling complex on the cardiomyocyte nuclear envelope. J. Cell Sci. 2001, 114:3167-3176.
51. Nicol R.L., Frey N., Pearson G., Cobb M., Richardson J., Olson E.N. Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. EMBO J. 2001, 20:2757-2767.
52. Dodge K.L., Khouangsathiene S., Kapiloff M.S., Mouton R., Hill E.V., Houslay M.D., Langeberg L.K., Scott J.D. mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module. EMBO J. 2001, 20:1921-1930.
53. Zhang L., Malik S., Kelley G.G., Kapiloff M.S., Smrcka A.V. Phospholipase C epsilon scaffolds to muscle-specific A kinase anchoring protein (mAKAPbeta) and integrates multiple hypertrophic stimuli in cardiac myocytes. J. Biol. Chem. 2011, 286:23012-23021.
54. Heineke J., Molkentin J.D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat. Rev. Mol. Cell Biol. 2006, 7:589-600.
55. Diviani D., Soderling J., Scott J.D. AKAP-Lbc anchors protein kinase A and nucleates Galpha 12-selective Rho-mediated stress fiber formation. J. Biol. Chem. 2001, 276:44247-44257.
56. Carnegie G.K., Soughayer J., Smith F.D., Pedroja B.S., Zhang F., Diviani D., Bristow M.R., Kunkel M.T., Newton A.C., Langeberg L.K., Scott J.D. AKAP-Lbc mobilizes a cardiac hypertrophy signaling pathway. Mol. Cell 2008, 32:169-179.
57. Smith F.D., Langeberg L.K., Cellurale C., Pawson T., Morrison D.K., Davis R.J., Scott J.D. AKAP-Lbc enhances cyclic AMP control of the ERK1/2 cascade. Nat. Cell Biol. 2010, 12:1242-1249.
58. Cariolato L., Cavin S., Diviani D. A-kinase anchoring protein (AKAP)-Lbc anchors a PKN-based signaling complex involved in alpha1-adrenergic receptor-induced p38 activation. J. Biol. Chem. 2011, 286:7925-7937.
59. Kehat I., Davis J., Tiburcy M., Accornero F., Saba-El-Leil M.K., Maillet M., York A.J., Lorenz J.N., Zimmermann W.H., Meloche S., Molkentin J.D. Extracellular signal-regulated kinases 1 and 2 regulate the balance between eccentric and concentric cardiac growth. Circ. Res. 2010, 108:176-183.
60. Streicher J.M., Ren S., Herschman H., Wang Y. MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart. Circ. Res. 2010, 106:1434-1443.
61. Carnegie G.K., Smith F.D., McConnachie G., Langeberg L.K., Scott J.D. AKAP-Lbc nucleates a protein kinase D activation scaffold. Mol. Cell 2004, 15:889-899.
62. Edwards H.V., Scott J.D., Baillie G.S. The A-kinase anchoring protein AKAP-Lbc facilitates cardioprotective PKA phosphorylation of Hsp20 on Serine 16. Biochem. J. 2012, (Epub ahead of print), doi.org/10.1042/BJ20120570.
63. Edwards H.V., Scott J.D., Baillie G.S. PKA phosphorylation of the small heat-shock protein Hsp20 enhances its cardioprotective effects. Biochem. Soc. Trans. 2012, 40:210-214.
64. Mayers C.M., Wadell J., McLean K., Venere M., Malik M., Shibata T., Driggers P.H., Kino T., Guo X.C., Koide H., Gorivodsky M., Grinberg A., Mukhopadhyay M., Abu-Asab M., Westphal H., Segars J.H. The Rho guanine nucleotide exchange factor AKAP13 (BRX) is essential for cardiac development in mice. J. Biol. Chem. 2010, 285:12344-12354.
65. Tevaearai H.T., Koch W.J. Trends molecular restoration of beta-adrenergic receptor signaling improves contractile function of failing hearts. Cardiovasc. Med. 2004, 14:252-256.
66. Rockman H.A., Koch W.J., Lefkowitz R.J. Seven-transmembrane-spanning receptors and heart function. Nature 2002, 415:206-212.
67. Laporte S.A., Miller W.E., Kim K.M., Caron M.G. beta-Arrestin/AP-2 interaction in G protein-coupled receptor internalization: identification of a beta-arrestin binging site in beta 2-adaptin. J. Biol. Chem. 2002, 277:9247-9254.
68. Laporte S.A., Oakley R.H., Holt J.A., Barak L.S., Caron M.G. The interaction of beta-arrestin with the AP-2 adaptor is required for the clustering of beta 2-adrenergic receptor into clathrin-coated pits. J. Biol. Chem. 2000, 275:23120-23126.
69. Naga Prasad S.V., Laporte S.A., Chamberlain D., Caron M.G., Barak L., Rockman H.A. Phosphoinositide 3-kinase regulates beta2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor/beta-arrestin complex. J. Cell Biol. 2002, 158:563-575.
70. Perino A., Ghigo A., Ferrero E., Morello F., Santulli G., Baillie G.S., Damilano F., Dunlop A.J., Pawson C., Walser R., Levi R., Altruda F., Silengo L., Langeberg L.K., Neubauer G., Heyman S., Lembo G., Wymann M.P., Wetzker R., Houslay M.D., Iaccarino G., Scott J.D., Hirsch E. Integrating cardiac PIP3 and cAMP signaling through a PKA anchoring function of p110γ. Mol. Cell 2011, 42:84-95.
71. Zakhary D.R., Moravec C.S., Bond M. Regulation of PKA binding to AKAPs in the heart: alterations in human heart failure. Circulation 2000, 101:1459-1464.
72. Swaney J.S., Roth D.M., Olson E.R., Naugle J.E., Meszaros J.G., Insel P.A. Inhibition of cardiac myofibroblast formation and collagen synthesis by activation and overexpression of adenylyl cyclase. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:437-442.
73. Kitamura K., Kangawa K., Matsuo H., Uyeda K. Phosphorylation of myocardial fructose-6-phosphate,2-kinase: fructose-2,6-bisphosphatase by cAMP-dependent protein kinase and protein kinase C. Activation by phosphorylation and amino acid sequences of the phosphorylation sites. J. Biol. Chem. 1988, 263:16796-16801.
74. Deprez J., Vertommen D., Alessi D.R., Hue L., Rider M.H. Phosphorylation and activation of heart 6-phosphofructo-2-kinase by protein kinase B and other protein kinases of the insulin signaling cascades. J. Biol. Chem. 1997, 272:17269-17275.
75. Papa S., Sardanelli A.M., Scacco S., Petruzzella V., Technikova-Dobrova Z., Vergari R., Signorile A. The NADH: ubiquinone oxidoreductase (complex I) of the mammalian respiratory chain and the cAMP cascade. J. Bioenerg. Biomembr. 2002, 34:1-10.